Healthcare provider profile · identity verified

Albert Izmaylov, M.D.

Internal Medicine · BROOKLYN, NY · NPI 1386880250

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	823	238
Amlodipine Besylate	Amlodipine Besylate	747	238
Metoprolol Succinate	Metoprolol Succinate	467	147
Albuterol Sulfate Hfa	Albuterol Sulfate	360	84
Rosuvastatin Calcium	Rosuvastatin Calcium	301	98
Pantoprazole Sodium	Pantoprazole Sodium	296	97
Omeprazole	Omeprazole	265	91
Clopidogrel	Clopidogrel Bisulfate	246	66
Levothyroxine Sodium	Levothyroxine Sodium	237	74
Lisinopril	Lisinopril	225	63
Furosemide	Furosemide	219	63
Gabapentin	Gabapentin	210	64
Prednisone	Prednisone	207	112
Eliquis	Apixaban	198	42
Azithromycin	Azithromycin	187	125
Fluticasone Propionate	Fluticasone Propionate	185	64
Tamsulosin Hcl	Tamsulosin Hcl	178	56
Metformin Hcl	Metformin Hcl	177	49
Metformin Hcl Er	Metformin Hcl	170	54
Losartan Potassium	Losartan Potassium	164	52
Diclofenac Sodium	Diclofenac Sodium	150	59
Meloxicam	Meloxicam	141	38
Simvastatin	Simvastatin	118	40
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	118	32
Vitamin D2	Ergocalciferol (Vitamin D2)	117	42
Glipizide Er	Glipizide	116	41
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	113	43
Zolpidem Tartrate	Zolpidem Tartrate	113	34
Valsartan	Valsartan	108	29
Nifedipine Er	Nifedipine	100	32
Carvedilol	Carvedilol	98	32
Montelukast Sodium	Montelukast Sodium	96	31
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	96	34
Alendronate Sodium	Alendronate Sodium	95	33
Enalapril Maleate	Enalapril Maleate	95	25
Linzess	Linaclotide	95	24
Chlorthalidone	Chlorthalidone	93	32
Hydrochlorothiazide	Hydrochlorothiazide	93	33
Naproxen	Naproxen	93	45
Famotidine	Famotidine	90	29
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	88	45
Labetalol Hcl	Labetalol Hcl	88	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	85	34
Baclofen	Baclofen	84	26
Alprazolam	Alprazolam	81	26
Finasteride	Finasteride	72	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	67	55
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	21
Breo Ellipta	Fluticasone/Vilanterol	66	suppressed
Diazepam	Diazepam	65	22
Januvia	Sitagliptin Phosphate	64	19
Trazodone Hcl	Trazodone Hcl	64	25
Doxycycline Hyclate	Doxycycline Hyclate	63	38
Escitalopram Oxalate	Escitalopram Oxalate	63	29
Meclizine Hcl	Meclizine Hcl	63	38
Entresto	Sacubitril/Valsartan	62	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	61	20
Hydralazine Hcl	Hydralazine Hcl	60	21
Ibuprofen	Ibuprofen	59	20
Clindamycin Phosphate	Clindamycin Phosphate	55	27
Sertraline Hcl	Sertraline Hcl	54	15
Tizanidine Hcl	Tizanidine Hcl	53	31
Duloxetine Hcl	Duloxetine Hcl	52	13
Metoprolol Tartrate	Metoprolol Tartrate	52	18
Ammonium Lactate	Ammonium Lactate	51	28
Olmesartan Medoxomil	Olmesartan Medoxomil	51	15
Alcohol Prep Pads	Alcohol Antiseptic Pads	50	17
Lidocaine	Lidocaine	48	14
Allopurinol	Allopurinol	47	17
Spironolactone	Spironolactone	46	19
Latanoprost	Latanoprost	43	11
Olanzapine	Olanzapine	43	18
Alfuzosin Hcl Er	Alfuzosin Hcl	42	15
Ezetimibe	Ezetimibe	42	14
Clonazepam	Clonazepam	41	suppressed
Jardiance	Empagliflozin	39	suppressed
Lactulose	Lactulose	39	11
Pregabalin	Pregabalin	38	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	37	14
Valacyclovir	Valacyclovir Hcl	37	17
Donepezil Hcl	Donepezil Hcl	36	11
Levetiracetam	Levetiracetam	36	suppressed
Potassium Chloride	Potassium Chloride	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	36	14
Xarelto	Rivaroxaban	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	26
Fluconazole	Fluconazole	33	22
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	suppressed
Promethazine Hcl	Promethazine Hcl	33	17
Glipizide	Glipizide	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Glimepiride	Glimepiride	31	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Atenolol	Atenolol	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Risperidone	Risperidone	27	suppressed
Clotrimazole	Clotrimazole	26	11
Lacosamide	Lacosamide	26	suppressed
Memantine Hcl Er	Memantine Hcl	26	suppressed
Single Use Swab	Alcohol Antiseptic Pads	26	14
Torsemide	Torsemide	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	24	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Anastrozole	Anastrozole	22	suppressed
Colchicine	Colchicine	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Megestrol Acetate	Megestrol Acetate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	14
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Nystatin	Nystatin	19	suppressed
Ramipril	Ramipril	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Metronidazole	Metronidazole	18	18
Mometasone Furoate	Mometasone Furoate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Brilinta	Ticagrelor	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Levofloxacin	Levofloxacin	16	16
Lubiprostone	Lubiprostone	16	suppressed
Primidone	Primidone	16	suppressed
Procto-Med Hc	Hydrocortisone	16	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Mupirocin	Mupirocin	15	11
Myrbetriq	Mirabegron	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Stribild	Elviteg/Cob/Emtri/Tenofo Disop	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Clonidine	Clonidine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Qnasl	Beclomethasone Dipropionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error